Resistance and Tolerance of Helicobacter pylori

Dear Colleagues,

Resistance to antibiotics is a global phenomenon generating huge costs and therapeutic difficulties. Therefore, monitoring of microbial resistance is one of the most important tasks of modern medicine. As a result of this, in 2017 the World Health Organization created a list of priority pathogens within which Helicobacter pylori was mentioned. The inclusion of this bacterium on the above list was associated with its ability to persistently colonize the host and induce a broad range of gastric diseases (including cancers), but was also related to the easiness of this pathogen to acquire resistance genes and become difficult to be treated.

The assumption of this Special Issue is to highlight the postulates of the WHO and to draw the attention of both scientists and clinicians to the importance of understanding mechanisms of H. pylori resistance and tolerance as a key strategy aimed at maintaining a high degree of eradication of this pathogen. As part of the Special Issue, we encourage to submit original research papers, short communications, and reviews describing the molecular phenomena responsible for the development of H. pylori antibiotic resistance, as well as the participation of complex physiological processes (biofilm production, transformation into coccoid forms, and secretion of membrane vesicles) in the tolerance or resistance of H. pylori to antimicrobial substances.

Dr. Paweł Krzyżek
Dr. Rossella Grande
Dr. Valentina Puca
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.